🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Reminder to grant reviewers - stay humble and constructive. You don’t want to be this reviewer. And for the applicants … stay positive and resilient. Celebrate your success. #ISCT2023

CAR T cell #immunotherapy in autoimmune disease- the origin story and current status Science Magazine science.org/content/articl…

#ScienceSaturday ❓ How can we enhance CAR-T cell activity against solid cancers? ➡️ In a recent study, Zhao et al transduced CAR-T to express IL-10, resulting in enhanced T-cell proliferation, effector function, mitochondrial capacity and antitumor activity in a variety of

CAR T cell therapy to solid tumors has proven challenging, and initial trials targeting solid tumors did not yield results as promising as those seen in blood cancers. The reason can be attributed to several specific hurdles ... nature.com/articles/s4158…

Always an inspiration to hear Dr Stephanie Goff present on #TILs. We need to stop thinking about this as palliative therapy! TILs have the potential to CURE- complete responders from National Cancer Institute with 10 year melanoma-specific survival of 96%. Unmodified TILs are just a starting

🌟 The Cellular Immunotherapies for Cancer lab wishes you a Merry Christmas and a Happy New Year! 🎄 May this holiday season bring joy, hope, and groundbreaking discoveries for all. Here’s to science turning our wishes into reality! 🔬✨

Hot off the press - an IGG gene signature links to longevity in breast cancer survivors, reduced death risk across cancers, and it correlates with TLS and B-/T-cell polyclonality. esmoopen.com/article/S2059-…

El management de la IA será más precocinado, la IA hará planes como churros, pero la esencia del management no cambiará, hacer que las cosas pasen y que pasen con sentido, hoy en La Vanguardia

📢 Our team at IDIBAPS-Hospital Clínic has developed and validated a new dual CAR-T therapy, ARI0003, for the treatment of non-Hodgkin lymphoma, now being tested in clinical trials. 🧵 A short thread sharing the key findings: clinicbarcelona.org/en/news/a-new-…

Happy to share our comment review in Nature Communications: “Unlocking the potential of engineered immune cell therapy for solid tumors”. Exciting future ahead 🚀 nature.com/articles/s4146… @prat_aleix Laura Angelats Alena Gros SoniaGuedan Julio Delgado Alvaro Urbano-Ispizua

I’ve been bullish on the idea that cancer will not be a disease my kids generation will die from We’ve made significant progress on a cure, but there’s still a lot keeping us from curing more than 10-20% of patients. But without govt funding it’s not happening. A quick thread 🧵

The Spring Scientific is almost here and will take place on March 12–14, 2025. #SITC will bring the brightest minds and next generation of leaders together to explore promising #science and develop novel opportunities to address these challenges. Register: go.sitcancer.org/4fupoc0

Today Nature Medicine! 🗞️ TILs Tumor Infiltrating Lymphocytes🔴🟠🟢 ➖a cell-based therapy for patients with colorectal & GI cancers➡️#immunotherapy. Responses➕“survivors” ➡️black arrows. 4️⃣>48-month survival ≈ CURES. Pembro⬆️responses. OncoAlert nature.com/articles/s4159…

Happy to be at #AACR25! Looking forward to witnessing new advances in #Immunotherapy and #CellTherapy 🧬🔬